Welltower Inc. $WELL Shares Purchased by Cullinan Associates Inc.

Cullinan Associates Inc. boosted its stake in Welltower Inc. (NYSE:WELL) by 8.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,215 shares of the real estate investment trust’s stock after buying an additional 750 shares during the period. Cullinan Associates Inc.’s holdings in Welltower were worth $1,417,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Nuveen LLC bought a new position in Welltower in the 1st quarter worth about $762,204,000. Price T Rowe Associates Inc. MD boosted its position in shares of Welltower by 41.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 8,923,852 shares of the real estate investment trust’s stock worth $1,367,226,000 after buying an additional 2,622,384 shares during the period. Wellington Management Group LLP boosted its position in shares of Welltower by 14.0% during the first quarter. Wellington Management Group LLP now owns 21,289,684 shares of the real estate investment trust’s stock worth $3,261,792,000 after buying an additional 2,614,562 shares during the period. Cbre Investment Management Listed Real Assets LLC boosted its position in shares of Welltower by 55.6% during the first quarter. Cbre Investment Management Listed Real Assets LLC now owns 3,013,247 shares of the real estate investment trust’s stock worth $461,660,000 after buying an additional 1,076,293 shares during the period. Finally, Ameriprise Financial Inc. boosted its position in shares of Welltower by 65.2% during the first quarter. Ameriprise Financial Inc. now owns 2,648,557 shares of the real estate investment trust’s stock worth $399,314,000 after buying an additional 1,045,507 shares during the period. 94.80% of the stock is owned by institutional investors and hedge funds.

Welltower Trading Down 0.1%

Shares of NYSE:WELL opened at $175.35 on Monday. The stock has a market capitalization of $117.28 billion, a price-to-earnings ratio of 99.07, a PEG ratio of 1.97 and a beta of 0.92. Welltower Inc. has a 1-year low of $122.34 and a 1-year high of $180.40. The company has a debt-to-equity ratio of 0.44, a quick ratio of 4.19 and a current ratio of 4.19. The company has a 50 day moving average price of $168.05 and a 200 day moving average price of $156.76.

Welltower (NYSE:WELL) last issued its earnings results on Monday, July 28th. The real estate investment trust reported $1.28 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.06. Welltower had a net margin of 12.18% and a return on equity of 3.38%. The firm had revenue of $2.55 billion during the quarter, compared to analysts’ expectations of $2.49 billion. During the same period last year, the firm posted $1.05 earnings per share. The firm’s revenue for the quarter was up 39.6% compared to the same quarter last year. Welltower has set its FY 2025 guidance at 5.060-5.14 EPS. On average, research analysts anticipate that Welltower Inc. will post 4.88 EPS for the current fiscal year.

Welltower Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 21st. Shareholders of record on Tuesday, August 12th were given a $0.74 dividend. This represents a $2.96 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Tuesday, August 12th. This is a positive change from Welltower’s previous quarterly dividend of $0.67. Welltower’s payout ratio is currently 167.23%.

Analyst Upgrades and Downgrades

WELL has been the subject of several analyst reports. UBS Group initiated coverage on Welltower in a research report on Friday, September 19th. They set a “buy” rating and a $195.00 price objective for the company. Scotiabank boosted their price objective on Welltower from $172.00 to $181.00 and gave the stock an “outperform” rating in a research report on Thursday, August 28th. Weiss Ratings reiterated a “buy (b)” rating on shares of Welltower in a research report on Saturday, September 27th. KeyCorp boosted their price objective on Welltower from $150.00 to $200.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 23rd. Finally, Cantor Fitzgerald initiated coverage on shares of Welltower in a report on Wednesday. They issued an “overweight” rating and a $195.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Welltower currently has an average rating of “Moderate Buy” and a consensus target price of $180.62.

Welltower Profile

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.